J Gastrointest Cancer9 Nov 2024
Among 107 patients with initially unresectable colorectal liver metastases undergoing conversion surgery, posthepatectomy liver failure (PHLF) occurred in 14% of cases. Multivariate analysis indicated that preoperative splenomegaly (greater than 135%) was an independent risk factor for PHLF, with an odds ratio of 14.30. Other contributing…
World J Surg Oncol7 Nov 2024
A study of 563 patients with pancreatic ductal adenocarcinoma revealed that the preoperative fibrinogen to pre-albumin ratio (FPR) serves as an independent prognostic indicator for recurrence-free survival (RFS) and overall survival (OS) following radical resection. With an optimal threshold of 14.77, patients were stratified into…
BJS Open6 Nov 2024
A new deep learning algorithm successfully distinguishes between desmoplastic and non-desmoplastic histopathological growth patterns in colorectal liver metastases, achieving high discriminatory power with area under the curve values of 0.93 and 0.95 during development and external validation, respectively. This automated classification parallels manual scoring regarding…
HPB & Spleen6 Nov 2024
A comprehensive study using MR-PheWAS and mendelian randomization demonstrated a causal association between pancreatic cancer and eosinophil counts, highlighting a notable correlation. Among 776 phenotypes analyzed, 41 showed significance, with specially validated results indicating that genetically predicted pancreatic cancer was linked to elevated eosinophils. This…
J Am Coll Surg5 Nov 2024
Implementation of a standardized trocar placement method using a 5-cm umbilicus incision combined with two robotic ports resulted in successful outcomes for robotic liver resection (RLR) and robotic pancreaticoduodenectomy (RPD) across a cohort of 60 patients. The approach achieved 82.8% uptake for RLR and 100%…
J Surg Oncol5 Nov 2024
A population-based analysis of 170,978 patients revealed that liver resection significantly enhances overall survival for those with colorectal liver metastases and concurrent extrahepatic disease. Among 62,003 patients with this dual condition, only 6% underwent liver resection, yet they experienced markedly better median overall survival (52…
Therap Adv Gastroenterol4 Nov 2024
A systematic review assessed the effectiveness of hepaticogastrostomy with antegrade stenting (hgas) compared to hepaticogastrostomy alone (hgs) for malignant biliary obstruction. Findings revealed pooled clinical success rates of 94% for hgas versus 88% for hgs, while re-intervention needs were significantly lower with hgas (OR=0.37). Although…
J Gastrointest Surg3 Nov 2024
The review delineates 'borderline resectable colorectal liver metastases' (BR-CRLM) as a distinct category, integrating both surgical and oncological criteria for optimal decision-making. Current treatments highlight the necessity of pre-operative chemotherapy and advanced surgical interventions, which now offer substantial long-term survival benefits. By emphasizing this classification,…
Appendix, Gallbladder and Surgical Emergencies3 Nov 2024
The PANORAMA study aims to assess how well New Zealand hospitals adhere to quality performance indicators (QPIs) for acute pancreatitis management. Researchers will gather data from adult patients diagnosed over a three-month period to evaluate compliance levels. In addition, the study will explore the connection…
J Hepatol2 Nov 2024
In a study involving 102 advanced biliary tract cancer patients, circulating tumor DNA (ctDNA) demonstrated an 84.8% sensitivity and a 79.4% positive predictive value compared to tissue genomic profiling. Targetable alterations were identified in 34.3% of patients, including mutations such as FGFR2 fusion and BRCA1/2…